Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Keri S. Kim

Keri S. Kim


Clinical Assistant Professor/Clinical Pharmacist, College of Pharmacy - Pharmacy Practice

Contact

Office Phone:

(312) 355-0784 (work)

Related Sites:

About Heading link

Research Interests:
Thrombosis and hemostasis

Teaching and Supervision Heading link

Undergrad Resrch Pharm Pract (PMPR 380), 1/8/2024 – 4/26/2024
Pathophysiology, Drug Action, & Therapeutics (PDAT) 7: Neurology, Psychiatry, & Pain (PHAR 507), 9/8/2023 – 9/11/2023
PDAT 3:Renal, Electro, Nutrtn (PHAR 503), 8/21/2023 – 12/1/2023
Undergrad Resrch Pharm Pract (PMPR 380), 8/21/2023 – 12/1/2023
PDAT 3:Renal, Electro, Nutrtn (PHAR 503), 8/21/2023 – 12/1/2023
PMPR 380 Course Information Undergraduate Research in Pharmacy Practice (CRN 12959) (PMPR 380), 1/9/2023 – 4/28/2023
PDAT 3:Renal, Electro, Nutrtn (PHAR 503), 8/22/2022 – 12/2/2022
PDAT 3:Renal, Electro, Nutrtn (PHAR 503), 8/22/2022 – 12/2/2022
PMPR 380 Course Information Undergraduate Research in Pharmacy Practice (CRN 12959) (PMPR 380), 8/22/2022 – 12/9/2022

Selected Grants

COVID19 Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP), Global Coalition for Adaptive Research., 6/16/2021 - 5/3/2022, Obligated Amount: $223052; Anticipated Amount: $223052

COVID19 Novel Experimental COVID Therapies Affecting Host Response (NECTAR) ACTIV 4d RAAS, Vanderbilt University Medical Center., 3/1/2021 - 8/1/2022, Obligated Amount: $270316; Anticipated Amount: $270316

Convalescent Plasma To Limit Coronavirus Associated Complications: A Randomized Blinded Phase 2 Study Comparing The Efficacy And Safety Of Anti-Sars-Cov-2 Plasma To Placebo In Covid-19 Hospitalized Pa, New York University School of Medicine., 2/15/2021 - 5/14/2021, Obligated Amount: $22501; Anticipated Amount: $22501

COVID19 CTA: ACTIV-IV Post Hospital Platform, University of Pittsburgh., 12/1/2020 - 11/30/2022, Obligated Amount: $4277904; Anticipated Amount: $4277904

COVID19 CTA - ACTIV-IV Post-Hospital Platform, University of Pittsburgh., 12/1/2020 - 11/30/2022, Obligated Amount: $1734537; Anticipated Amount: $1883768

Thrombotic Complications in COVID-19 Pneumonia Compared to Bacterial Pneumonia and Viral Pneumonia, University of Illinois Health., 11/2/2020 - 12/31/2021, No Obligated Amount Set; No Anticipated Amount Set

Thrombotic Complications in COVID-19 Pneumonia Compared to Bacterial Pneumonia and Viral Pneumonia, University of Illinois Health., 11/2/2020 - 12/31/2021, No Obligated Amount Set; No Anticipated Amount Set

COVID19 A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitals Adults with COVID-19, New York University School of Medicine., 9/25/2020 - 5/31/2023, Obligated Amount: $851000; Anticipated Amount: $851000

CTA: COVID19 ACTIV-IV Inpatient Platform (ACTIV4a), University of Pittsburgh., 7/1/2020 - 5/31/2023, Obligated Amount: $1273013; Anticipated Amount: $1273013

Selected Publications

Muehlschlegel, Susanne, Rajajee, Venkatakrishna, Wartenberg, Katja E, Alexander, Sheila A, Busl, Katharina M, Creutzfeldt, Claire J, Fontaine, Gabriel V, Hocker, Sara E, Hwang, David Y, Kim, Keri S, Madzar, Dominik, Mahanes, Dea, Mainali, Shraddha, Meixensberger, Juergen, Sakowitz, Oliver W, Varelas, Panayiotis N, Weimar, Christian, Westermaier, Thomas. (2024). Guidelines for Neuroprognostication in Critically Ill Adults with Moderate–Severe Traumatic Brain Injury. Neurocritical Care, 40, (2), 448-476. doi:10.1007/s12028-023-01902-2.

Mahanes, Dea, Muehlschlegel, Susanne, Wartenberg, Katja E, Rajajee, Venkatakrishna, Alexander, Sheila A, Busl, Katharina M, Creutzfeldt, Claire J, Fontaine, Gabriel V, Hocker, Sara E, Hwang, David Y, Kim, Keri S, Madzar, Dominik, Mainali, Shraddha, Meixensberger, Juergen, Varelas, Panayiotis N, Weimar, Christian, Westermaier, Thomas, Sakowitz, Oliver W. (2024). Guidelines for neuroprognostication in adults with traumatic spinal cord injury. Neurocritical Care, 40, (2), 415-437. doi:10.1007/s12028-023-01845-8.

Hwang, David Y, Kim, Keri S, Muehlschlegel, Susanne, Wartenberg, Katja E, Rajajee, Venkatakrishna, Alexander, Sheila A, Busl, Katharina M, Creutzfeldt, Claire J, Fontaine, Gabriel V, Hocker, Sara E, Madzar, Dominik, Mahanes, Dea, Mainali, Shraddha, Sakowitz, Oliver W, Varelas, Panayiotis N, Weimar, Christian, Westermaier, Thomas, Meixensberger, Jürgen. (2024). Guidelines for Neuroprognostication in Critically Ill Adults with Intracerebral Hemorrhage. Neurocritical Care, 40, (2), 395-414. doi:10.1007/s12028-023-01854-7.

Godoy, Lucas C, Neal, Matthew D, Goligher, Ewan C, Cushman, Mary, Houston, Brett L, Bradbury, Charlotte A, McQuilten, Zoe K, Tritschler, Tobias, Kahn, Susan R, Berry, Lindsay R, Lorenzi, Elizabeth, Jensen, Tom, Higgins, Alisa M, Kornblith, Lucy Z, Berger, Jeffrey S, Gong, Michelle N, Paul, Jonathan D, Castellucci, Lana A, Le Gal, Grégoire, Lother, Sylvain A, Rosenson, Robert S, Derde, Lennie PG, Kumar, Anand, McVerry, Bryan J, Nicolau, Jose C, Leifer, Eric, Escobedo, Jorge, Huang, David T, Reynolds, Harmony R, Carrier, Marc, Kim, Keri S, Hunt, Beverley J, Slutsky, Arthur S, Turgeon, Alexis F, Webb, Steven A, McArthur, Colin J, Farkouh, Michael E, Hochman, Judith S, Zarychanski, Ryan, Lawler, Patrick R. (2024). Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19. JACC Advances, 3, (3), 100780. doi:10.1016/j.jacadv.2023.100780.

Beqiri, Erta, Badjatia, Neeraj, Ercole, Ari, Foreman, Brandon, Hu, Peter, Hu, Xiao, LaRovere, Kerri, Meyfroidt, Geert, Moberg, Dick, Robba, Chiara, Rosenthal, Eric S, Smielewski, Peter, Wainwright, Mark S, Park, Soojin. (2024). Correction: Common Data Elements for Disorders of Consciousness: Recommendations from the Working Group on Physiology and Big Data. Neurocritical Care, 40, (1), 382-383. doi:10.1007/s12028-023-01894-z.

Yakhkind, Aleksandra, Niznick, Naomi, Bodien, Yelena G, Hammond, Flora M, Katz, Douglas, Luaute, Jacques, McNett, Molly, Naccache, Lionel, O’Brien, Katherine, Schnakers, Caroline, Sharshar, Tarek, Slomine, Beth S, Giacino, Joseph T. (2024). Correction: Common Data Elements for Disorders of Consciousness: Recommendations from the Working Group on Behavioral Phenotyping. Neurocritical Care, 40, (1), 384-384. doi:10.1007/s12028-023-01874-3.

Barra, Megan E, Zink, Elizabeth K, Bleck, Thomas P, Cáceres, Eder, Farrokh, Salia, Foreman, Brandon, Cediel, Emilio Garzón, Hemphill, J Claude, Nagayama, Masao, Olson, DaiWai M, Suarez, Jose I. (2023). Common Data Elements for Disorders of Consciousness: Recommendations from the Working Group on Hospital Course, Confounders, and Medications. Neurocritical Care, 39, (3), 586-592. doi:10.1007/s12028-023-01803-4.

Edlow, Brian L, Boerwinkle, Varina L, Annen, Jitka, Boly, Melanie, Gosseries, Olivia, Laureys, Steven, Mukherjee, Pratik, Puybasset, Louis, Stevens, Robert D, Threlkeld, Zachary D, Newcombe, Virginia FJ, Fernandez-Espejo, Davinia. (2023). Common Data Elements for Disorders of Consciousness: Recommendations from the Working Group on Neuroimaging. Neurocritical Care, 39, (3), 611-617. doi:10.1007/s12028-023-01794-2.

Busl, Katharina M, Fried, Herbert, Muehlschlegel, Susanne, Wartenberg, Katja E, Rajajee, Venkatakrishna, Alexander, Sheila A, Creutzfeldt, Claire J, Fontaine, Gabriel V, Hocker, Sara E, Hwang, David Y, Kim, Keri S, Madzar, Dominik, Mahanes, Dea, Mainali, Shraddha, Meixensberger, Juergen, Sakowitz, Oliver W, Varelas, Panayiotis N, Westermaier, Thomas, Weimar, Christian. (2023). Author Correction: Guidelines for Neuroprognostication in Adults with Guillain–Barré Syndrome. Neurocritical Care, 39, (3), 752-752. doi:10.1007/s12028-023-01830-1.

Professional Leadership

Curing Coma Campaign (Acknowledgement), 3/31/2023 - 3/31/2023

Curing Coma Campaign (Acknowledgement), Neurocritical Care Society, 3/28/2023 - 3/28/2023

Curing Coma Campaign (Acknowledgement), Neurocritical Care Society, 7/8/2021 - 7/8/2021

Neurocritical Care Society (NCS) Guidelines Committee, Neurocritical Care Society (NCS), 10/1/2020 - 9/30/2024

Neurocritical Care Research Network (NCRN), Neurocritical Care Society (NCS), 1/1/2020 - Present

Neurocritical Care Society (NCS) Research Operations Sub-Committee, Neurocritical Care Society (NCS), 10/1/2017 - 9/30/2021

Notable Honors

2022, 2022 Presidential Citation Award, Neurocritical Care Society

2022, 2022 Fellow of Neurocritical Care Society (FNCS), Neurocritical Care Society

2020, 2020 Presidential Citation Award, Neurocritical Care Society

Education

Degrees:
Master of Science in Clinical and Translation Science (MS CTS), University of Illinois at Chicago, United States, 2010
Doctor of Pharmacy, University of Illinois at Chicago, United States, 2003
Pre-Pharmacy Curriculum, University of Illinois at Chicago, United States, 1999

Postgraduate Training:
Critical Care Specialty Resident, Virginia Commonwealth University, United States, 2005
Pharmacy Practice Resident, University of Illinois at Chicago College of Pharmacy, United States, 2004

Licensures and Certifications

Board Certified Pharmacotherapy Specialist, American College of Clinical Pharmacy, 11/2005 - Present
Teaching Certificate Program, University of Illinois at Chicago, 7/2004 - Present
Advanced Cardiac Life Support Provider, American Heart Association, 7/2003 - Present
Basic Life Support Provider, American Heart Association, 1/2003 - Present
Pharmacists-Based Immunization Delivery, American Pharmacists Association Foundation, 1/2003 - Present
Pharmacist, Illinois Board of Pharmacy, 8/2003 - Present
Pharmacist, Virginia Board of Pharmacy, 8/2004 - 12/2005
Pharmacist, Texas Board of Pharmacy, 3/2019 - Present